We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.28%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$118B
AUM Growth
+$8.59B
Cap. Flow
-$401M
Cap. Flow %
-0.34%
Top 10 Hldgs %
16.92%
Holding
8,702
New
1,333
Increased
3,126
Reduced
2,721
Closed
1,293

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$346M
2
AVGO icon
Broadcom
AVGO
+$326M
3
BA icon
Boeing
BA
+$263M
4
COF icon
Capital One
COF
+$258M
5
OXY icon
Occidental Petroleum
OXY
+$257M

Sector Composition

Rank Sector Weight
1 Technology 7.15%
2 Financials 5.56%
3 Consumer Discretionary 5.28%
4 Industrials 4.73%
5 Healthcare 4.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TESO
6876
DELISTED
Tesco Corp
TESO
$62K ﹤0.01%
13,915
+481
+4% +$2.65K
LGL icon
6877
LGL Group
LGL
$47.3M
$61K ﹤0.01%
+33,492
New +$61K
MTNB icon
6878
Matinas BioPharma
MTNB
$1.71M
$61K ﹤0.01%
+722
New +$96.9K
MVIS icon
6879
CALL
Microvision
MVIS
$93.6M
$61K ﹤0.01%
1,927
-1,166
-38% -$37.5K
ARTX
6880
DELISTED
Arotech Corporation
ARTX
$61K ﹤0.01%
17,271
-975
-5% -$3.21K
AST
6881
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$61K ﹤0.01%
+17,251
New +$56.8K
OREX
6882
DELISTED
Orexigen Therapeutics, Inc.
OREX
$61K ﹤0.01%
+20,920
New +$62.8K
NYMX
6883
PUT
DELISTED
Nymox Pharmaceutical Corp
NYMX
$60K ﹤0.01%
13,600
-23,700
-64% -$97.3K
MTL
6884
PUT
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$60K ﹤0.01%
13,000
+1,000
+8% +$5.21K
OCSL icon
6885
PUT
Oaktree Specialty Lending
OCSL
$1.12B
$59K ﹤0.01%
+4,067
New +$52K
VNET
6886
PUT
VNET Group
VNET
$2.11B
$59K ﹤0.01%
11,700
-3,000
-20% -$16.2K
CMRX
6887
CALL
DELISTED
Chimerix, Inc.
CMRX
$59K ﹤0.01%
+10,900
New +$57.3K
DNR
6888
CALL
DELISTED
Denbury Resources, Inc.
DNR
$59K ﹤0.01%
38,500
-34,100
-47% -$63.7K
SMI
6889
DELISTED
Semiconductor Manufacturing Intl
SMI
$59K ﹤0.01%
+10,391
New +$58.8K
SVM
6890
Silvercorp Metals
SVM
$2.66B
$58K ﹤0.01%
+18,296
New +$55.7K
VVR icon
6891
Invesco Senior Income Trust
VVR
$457M
$58K ﹤0.01%
+12,723
New +$59.1K
GLBR
6892
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
$58K ﹤0.01%
+29,023
New +$59.8K
AVXL icon
6893
PUT
Anavex Life Sciences
AVXL
$313M
$57K ﹤0.01%
10,800
-2,100
-16% -$12.1K
DHF
6894
BNY Mellon High Yield Strategies Fund
DHF
$173M
$57K ﹤0.01%
+16,211
New +$56.6K
GNCA
6895
DELISTED
Genocea Biosciences, Inc.
GNCA
$57K ﹤0.01%
+1,373
New +$66.1K
NBEV
6896
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$56K ﹤0.01%
+11,005
New +$54.3K
GPL
6897
CALL
DELISTED
Great Panther Mining Limited
GPL
$56K ﹤0.01%
4,340
-2,010
-32% -$25.9K
GSS
6898
CALL
DELISTED
Golden Star Resources Ltd.
GSS
$56K ﹤0.01%
17,360
+2,820
+19% +$10.1K
AMSC icon
6899
American Superconductor
AMSC
$1.56B
$55K ﹤0.01%
11,845
+494
+4% +$2.51K
NMM icon
6900
Navios Maritime Partners
NMM
$2.24B
$55K ﹤0.01%
2,304
+1,370
+147% +$36.8K

Similar funds

Citadel Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, Citadel Advisors held 8,702 positions worth $118B, up 7.8% from $109B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Citadel Advisors's Q2 2017 filing shows 1,333 new, 3,126 increased, 2,721 reduced and 1,293 closed positions. Its largest new stake was Equity Residential: 2,436,064 shares worth $160M. The largest sale was Walt Disney, an estimated $550M.

By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 7.1% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Citadel Advisors's largest Q2 2017 buy was Equity Residential: 2,436,064 shares worth $160M.
  • Citadel Advisors added most to Applied Materials in Q2 2017, an estimated $346M increase.
  • Citadel Advisors's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $549M.
  • Citadel Advisors fully exited Walt Disney in Q2 2017, selling an estimated $550M.
  • Citadel Advisors's ten largest holdings make up 17% of its $118B portfolio in Q2 2017.
  • Citadel Advisors opened 1,333 new positions and closed 1,293 in Q2 2017.
  • Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $118B.

Based on Citadel Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.